Lumateperone 42 mg in an Open-Label Switch Study in Patients with Stable Schizophrenia: Results by Previous Antipsychotic

被引：0
|
作者：
Cutler, Andrew J. [1 ]
Edwards, John B. [2 ]
Durgam, Suresh [2 ]
Mo, Yifan [2 ]
Acosta, Jazmin [2 ]
Davis, Robert E. [2 ]
机构：
[1] SUNY Upstate Med Univ, Dept Psychiat, Lakewood Ranch, FL USA
[2] Intra Cellular Therapies Inc, New York, NY USA
来源：
CNS SPECTRUMS | 2023年 / 28卷 / 02期
关键词：
D O I：
10.1017/S1092852923001645
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：235 / 236
页数：2
相关论文
共 50 条
  • [21] Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia
    Rosenthal, MH
    Bryant, S
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 301 - 301
  • [22] Safety and efficacy of long-acting risperidone in schizophrenia: A 12-week open-label study in stable patients switched from oral antipsychotic treatment
    Lindenmayer, J
    Eerdekens, E
    Berry, S
    Eerdekens, M
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 173 - 173
  • [23] Open-label study results of conivaptan in patients with severe hyponatremia
    Wagoner, Lynne E.
    Rosansky, Steven
    Verbalis, Joseph G.
    McNutt, Bruce
    Yan, Bo
    CRITICAL CARE MEDICINE, 2007, 35 (12) : A18 - A18
  • [24] LUMATEPERONE (ITI-007): FAVORABLE SAFETY PROFILE IN AN OPEN LABEL SAFETY SWITCHING STUDY FROM STANDARD-OF-CARE ANTIPSYCHOTIC THERAPY IN PATIENTS WITH SCHIZOPHRENIA
    Davis, Robert
    Dmitrienko, Alex
    Glass, Steven
    Kozauer, Susan
    Saillard, Jelena
    Weingart, Michal
    Satlin, Andrew
    Mates, Sharon
    Correll, Christoph
    Vanover, Kimberly
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S236 - S237
  • [25] AMISULPRIDE IMPROVES OBSESSIVE-COMPULSIVE SYMPTOMS IN SCHIZOPHRENIA PATIENTS TAKING ATYPICAL ANTIPSYCHOTICS: AN OPEN-LABEL SWITCH STUDY
    Kim, Sung-Wan
    Shin, I. S.
    Kim, J. M.
    Yang, S. J.
    Youn, T.
    Yoon, J. S.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 367 - 367
  • [26] Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics - An open-label switch study
    Kim, Sung-Wan
    Shin, Il-Seon
    Kim, Jae-Min
    Yang, Su-Jin
    Hwang, Michael Y.
    Yoon, Jin-Sang
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (03) : 349 - 352
  • [27] Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: An open-label switch study
    Kim, S. -W.
    Pac, J. -W.
    Kim, J. -M.
    Shin, I. S.
    Yang, S. -J.
    Bae, K. -R.
    Kim, S. -Y.
    Hwang, M.
    Yoo, J. -A.
    Yoon, J. S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 133 - 133
  • [28] AN OPEN-LABEL STUDY OF FAMOTIDINE AS A TREATMENT FOR SCHIZOPHRENIA - REPLY
    OYEWUMI, LK
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1995, 20 (03): : 240 - 240
  • [29] Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
    Miyaoka, Tsuyoshi
    Yasukawa, Rei
    Yasuda, Hideaki
    Hayashida, Maiko
    Inagaki, Takuji
    Horiguchi, Jun
    CLINICAL NEUROPHARMACOLOGY, 2008, 31 (05) : 287 - 292
  • [30] Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
    Miyaoka, Tsuyoshi
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 91S - 91S
12345